A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction
摘要:
K+ channels containing Kv1.1 alpha subunits, which become prevalent at internodes in demyelinated axons, may underlie their dysfunctional conduction akin to muscle weakness in multiple sclerosis. Small inhibitors were sought with selectivity for the culpable hyper-polarizing K+ currents. Modeling of interactions with the extracellular pore in a Kv1.1-deduced structure identified diaryldi(2-pyrrolyeinethane as a suitable scaffold with optimized alkyl ammonium side chains. The resultant synthesized candidate [2,2'-((5,5'(di-p-topyldiaryldi(2-pyrrolyl)methane)bis(2,2'-carbonyl)bis(azanediyl)) diethaneamine center dot 2HCl] (8) selectively blocked Kv1.1 channels (IC50 approximate to 15 mu M) recombinantly expressed in mammalian cells, induced a positive shift in the voltage dependency of K4 current activation, and slowed its kinetics. It preferentially inhibited channels containing two or more Kv1.1 subunits regardless of their positioning in concatenated tetramers. In slices of corpus callosum from mice subjected to a demyelination protocol, this novel inhibitor improved neuronal conduction, highlighting its potential for alleviating symptoms in multiple sclerosis.
A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction
摘要:
K+ channels containing Kv1.1 alpha subunits, which become prevalent at internodes in demyelinated axons, may underlie their dysfunctional conduction akin to muscle weakness in multiple sclerosis. Small inhibitors were sought with selectivity for the culpable hyper-polarizing K+ currents. Modeling of interactions with the extracellular pore in a Kv1.1-deduced structure identified diaryldi(2-pyrrolyeinethane as a suitable scaffold with optimized alkyl ammonium side chains. The resultant synthesized candidate [2,2'-((5,5'(di-p-topyldiaryldi(2-pyrrolyl)methane)bis(2,2'-carbonyl)bis(azanediyl)) diethaneamine center dot 2HCl] (8) selectively blocked Kv1.1 channels (IC50 approximate to 15 mu M) recombinantly expressed in mammalian cells, induced a positive shift in the voltage dependency of K4 current activation, and slowed its kinetics. It preferentially inhibited channels containing two or more Kv1.1 subunits regardless of their positioning in concatenated tetramers. In slices of corpus callosum from mice subjected to a demyelination protocol, this novel inhibitor improved neuronal conduction, highlighting its potential for alleviating symptoms in multiple sclerosis.
A two-step synthesis of 5,5-diaryldipyrromethanes in good yields is described. The adopted synthetic strategy can be used to tune the substituent at the meso-carbon very easily by choosing the Grignard reagent of interest. Further, the influence of the incorporation of various diaryl units at the mesa-carbon atom in the inherent anion binding affinities of the dipyrromethanes through hydrogen bonding was discussed. (C) 2011 Elsevier Ltd. All rights reserved.
A Rational Design of a Selective Inhibitor for Kv1.1 Channels Prevalent in Demyelinated Nerves That Improves Their Impaired Axonal Conduction
作者:Ahmed Al-Sabi、Declan Daly、Patrick Hoefer、Gemma K. Kinsella、Charles Metais、Mark Pickering、Caroline Herron、Seshu Kumar Kaza、Kieran Nolan、J. Oliver Dolly
DOI:10.1021/acs.jmedchem.6b01262
日期:2017.3.23
K+ channels containing Kv1.1 alpha subunits, which become prevalent at internodes in demyelinated axons, may underlie their dysfunctional conduction akin to muscle weakness in multiple sclerosis. Small inhibitors were sought with selectivity for the culpable hyper-polarizing K+ currents. Modeling of interactions with the extracellular pore in a Kv1.1-deduced structure identified diaryldi(2-pyrrolyeinethane as a suitable scaffold with optimized alkyl ammonium side chains. The resultant synthesized candidate [2,2'-((5,5'(di-p-topyldiaryldi(2-pyrrolyl)methane)bis(2,2'-carbonyl)bis(azanediyl)) diethaneamine center dot 2HCl] (8) selectively blocked Kv1.1 channels (IC50 approximate to 15 mu M) recombinantly expressed in mammalian cells, induced a positive shift in the voltage dependency of K4 current activation, and slowed its kinetics. It preferentially inhibited channels containing two or more Kv1.1 subunits regardless of their positioning in concatenated tetramers. In slices of corpus callosum from mice subjected to a demyelination protocol, this novel inhibitor improved neuronal conduction, highlighting its potential for alleviating symptoms in multiple sclerosis.